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The amount of clinical trials moving through the clinical trial lifecycle pipeline 
continues to increase every year. From 2000 to 2013, the number of registered clinical trials 
increased by two orders of magnitude. Also increasing are the amount of steps and processes 
both scientific and administrative required for a clinical trial to proceed through the pipeline. 
This trend contributes to increasing study complexity and burden of work on clinical research 
administrators. Traditional methods of facilitating and completing clinical research 
administrative tasks may not be effective in dealing with increasing numbers of simultaneous 
trials and increasing number of required processes to complete. There is a risk of further 
increasing the time of the clinical trial lifecycle due to overloaded clinical research 
administration. In this paper, concepts of clinical data management are introduced in the 
context of clinical research administration. Key data points common within clinical research 
administrative activities are presented, along with application of that data in improving 
clinical research administration efficiency through both non-programmatic and programmatic 
automation, reducing administrative work burden, costs, and ensuring current turnaround 
time for work processes will not be impacted by increasing workload.  
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Chapter 1. Introduction 
1.1. Background 
The number of clinical research trials being conducted continues to grow every year, 
along with clinical trial design and procedural complexity. The number of processes and 
procedures required to successfully execute a clinical trial have increased both for medical 
personnel and administrative personnel. The literature documents an increasing amount of 
trial procedures over time identified by in-depth analysis of institution-level processes and 
commonalities across institutions in executing a clinical trial. Also available is research into 
the impact of complexity on study outcomes, such as recruiting the required number of  
subjects for the study or ensuring appropriate timelines are met. Literature also exists 
discussing the impact of complexity on study workload and the increasing burden it presents 
on personnel at all stages of the clinical trial life cycle. In particular, steps in the process with 
the most significant impact on study workload were those deemed repetitive or that involved 
numerous parties.  
Research into methods of assessing and alleviating study complexity have been 
conducted. Some researchers have presented scoring criteria to assess study design in order to 
better understand the impact a study’s complexity may have on the workload of employees 
from an institution participating in a clinical trial as a study site. Other researchers have 
proposed a data science approach to assess study design and during concept development and 
workload impact after study approval. However, no research provides a practical and 
immediately implementable measure that equips institutions and clinical research 
administrators to handle increasing workload in clinical research administration. 
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1.2. Statement of the Problem 
 
None of the literature addresses the need for clinical research administration to be 
equipped with new skill sets that prepare them for the trend of increasing study numbers and 
complexity, thus mitigating some of the negative impacts of large amounts of complex 
studies at a grass-roots level. Furthermore, none of the literature provides practical and 
immediately implementable steps that a clinical research administrator may take to alleviate 
the increased work burden of managing more studies every year that are increasing in 
complexity. Options that are available for clinical research administrators to handle 
increasing work burden are presented in this paper. 
1.3. Research Questions 
 
How can clinical research administrators and institutions benefit from applying data 
management principles? How can automation be applied to clinical research administration? 
What are some tasks in different areas within clinical research administration that can serve 
as examples of how to apply data management and automation principles? How can clinical 
research administrators accurately identify steps or tasks within their administrative processes 
that could be augmented by data management principles and automation? 
1.4. Objectives 
 
Methods to improve efficiency and prepare for larger clinical research administration 
workloads by using data management and automation will be explored. The concepts of data 
management, data management plans, data quality, ways to use data, and automation will be 
presented and reviewed. An approach will be developed on how to adapt the concepts of data 
management and automation to clinical research administration in a way to improve 
efficiency.  A way to think about data management and automation from a clinical research 
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administration standpoint will be developed as well as how to assess internal processes for 
opportunities to apply data management and automation to improve work efficiency. 
Different approaches will be evaluated using practical scenarios and easily repurposed 
materials. Finally, code written specifically for this paper will be provided, along with 
detailed instructions, that demonstrate how data management principles can enable clinical 
research administrators to automate tasks and improve efficiency. 
1.5. Significance 
The significance of this project is two-fold. First, this project introduces clinical 
research administrators to technological approaches that have been trending in other 
industries for years. These industries have used this technology for operationally beneficial 
applications, such as forecasting project workload, predicting project success, and automating 
a plethora of tasks, thus freeing up resources for more mission-critical work. As trends 
indicate that the number of clinical trials will not only continue to increase in number, but in 
complexity as well, it is vital that approaches to clinical research administration tasks adapt to 
a higher volume of work at a fundamental level. Specifically, clinical research administrators 
must look at the processes and procedures they directly execute on a daily basis and identify 
opportunities to improve efficiency in these processes and procedures through readily 
available technologies. This approach frees up time to either handle other tasks critical to 
their institution’s mission or to further prepare their institution’s clinical research 
administration processes for the future. 
Second, this project is significant in its potential to further drive changes to how 
clinical research is conducted. Numerous organizations both public and private agree that the 
way clinical research is designed, developed, and conducted is inefficient and takes too much 
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time. By adopting new technologies and schools of thought from other professional fields, 
clinical research administrators could drive transformation in clinical research execution from 
a grass-roots level by harnessing data and automation. This grass-roots approach could enable 
institutions to more quickly adopt new technologies and deploy them on a broad scale, as 
their own personnel could demonstrate the technologies benefits.  
1.6. Limitations – The Nature of Clinical Research Administration 
The scope of work for clinical research administration professionals can vary greatly. 
Whether responsible for safety committee organization, study accrual monitoring, case report 
form (CRF) development, or protocol amendment analysis, clinical research administrators 
can be found at almost any part of the clinical trial lifecycle. While as many examples as 
possible will be covered, this paper is unable to cover every possible process or task that a 
clinical research administrator may face. The goal is to provide readers with an introduction 
to the concepts of data management and automation in the context of example tasks clinical 
research administrators in different institutions and organizations may face.  
Chapter 2. Literature Review 
 
2.1. Overview of Literature Review 
 
The National Institutes of Health (NIH) tracks the number of registered clinical trials 
over time at the ClinicalTrials.gov website, starting from the year 2000 up to 20181. Records 
indicate that from 2000 to 2013 the number of registered clinical trials increased by two 
orders of magnitude, from 1,255 registered trials to 137,532. As of October 2018, there are 
262,431 registered clinical trials. Calculating the average percentage increase of registered 
trials per year from 2000 to 2018 yields an average increase in registered clinical trials per 
                                                 
1 National Institutes of Health. (2018). ClinicalTrials.gov Trends, Charts, and Maps. From 
https://clinicaltrials.gov/ct2/resources/trends 
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year of 1,156%. The number of registered clinical trials compounded by the amount of 
studies involving multiple hospitals as study sites, all with differing processes and 
procedures, paints a more specific image of what the clinical research administration 
landscape may look like in the future should these trends continue. 
Getz and Campo monitored and assessed the state of clinical trial complexity over the 
course of 14 years. In their publication titled New Benchmarks Characterizing Growth in 
Protocol Design Complexity, they found that of the sites monitored, the mean number of total 
procedures to execute for a clinical trial increased for all phases across all therapeutic areas2. 
These results reflect an increase in workload needed to execute all required procedures both 
medical and administrative in a clinical trial. The average increase of total procedures for a 
clinical trial was 202 for Phase I studies, 177 for Phase II studies, and 150 for Phase III. With 
all Phases experiencing increases in total procedures, traditional approaches to completing 
clinical research administration tasks may not be sufficient enough to keep up with the 
increasing administrative workload.  
A study by Dilts et al. sought to map all processes and procedures for Phase III 
cooperative group clinical trials from first inception as a concept at an institution to study 
opening and participant registration. By analyzing electronic records, trial initiation data, and 
process documentation, they found that 769 steps were required to open the Phase III study3. 
In their analysis, they identified two types of processes required to open the study. Work 
steps were activities that needed to be performed before a study could open. Decision points 
determined routes where the products of work steps would go if they met a certain criterion. 
                                                 
2 Getz, K., Campo, R. (2017) New Benchmarks Characterizing Growth in Protocol Design Complexity. doi: 
10.1177/2168479017713039 
3 Dilts et al. (2010). Phase III Clinical Trial Development: A Process of Chutes and Ladders. doi: 10.1158/1078-
0432.CCR-10-1273 
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Of the 769 steps identified, 84% were work steps, the majority of which were clinical 
research administrative tasks ranging from form development to communication and 
coordination. The authors noted that there is a risk that some work steps could be slowed 
down or overwhelmed should higher volumes of more complex clinical trials begin to flow 
through these process routes. Of more concern is the additional slow-down that could occur 
should certain steps require repeating. The authors compared the process to the child’s game 
Chutes and Ladders, illustrating how many steps act as chutes, requiring that they be 
completed again (up to six times in some cases). The authors also noted concerns about how 
much overwhelmed administrative processes would further increase the time taken to 
complete the clinical trial lifecycle, and thus increase the time that possible life saving 
therapeutic innovations take to reach patients in need.   
Getz further elucidates the nature of clinical “chutes” and their impact on clinical 
research administrator work burden in an article focused on a familiar topic to many clinical 
research administrators; protocol amendments. In Measuring the Incidence, Causes, and 
Repercussions of Protocol Amendments, Getz presents his results from monitoring changes to 
3,410 clinical protocols over a two to four-year period4. Of these protocols, 6,855 protocol 
amendment changes were categorized. 39% were modifications to the eligibility criteria 
description, adjustments to the number and types of safety assessments, and alterations of 
general protocol information (e.g. contact information, site information, etc.). The median 
time taken to implement changes was 65 days, with almost half of that time used on finding 
the correct way to rewrite the protocol to accurately reflect the amendment. This process can 
involve a significant amount of back and forth communication between clinical research 
                                                 
4 Getz et al. (2011). Measuring the Incidence, Causes, and Repercussions of Protocol Amendments. doi: 
10.1177/009286151104500307 
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administrators, medical practitioners, and others before a revised protocol is generated that all 
parties find agreeable. More than half of amendments made in Phase I studies occurred before 
first patient enrollment, with one-third of all amendments being classified as avoidable (i.e. 
caused by human error). This outcome is interesting when considering Getz findings in 
Trends in clinical trial design complexity from 2017, where he reported on a positively 
correlating trend between study complexity and protocol amendment amount continuing with 
no sign of slowing down5. 
Dilts and Sandler dedicated a project to assess the clinical research administration 
barriers to opening clinical trials, where they identify redundancies and deficiencies present 
between administrative departments within their target institution and their interactions with 
external entities6. Note that in the process map presented in Figure 1 of Invisible Barriers to 
clinical Trials, a single work step submitting some forms comes before a large series of 
reviews and approvals. Before that step are two steps related to form preparation. From an 
administrative standpoint, this step is crucial to ensure research activities can proceed in a 
timely manner. However, consider this subset of the greater clinical trial development process 
while accounting for the trend of increasing clinical trial numbers and complexity. There is a 
risk of a bottleneck emerging should a clinical research administrator not be well equipped to 
handle a significant number of forms for complex studies. 
Concerns over operational efficiency in clinical research administration have not gone 
unvoiced by professionals in the field. Additionally, possible solutions and approaches that 
enable clinical research administrators to improve operational efficiency have been written 
on. In 2017, Regan wrote on the ways technology could improve clinical research execution. 
                                                 
5 Getz, K., Campo, R. (2017). Trial Watch, Trends in clinical trial design complexity. doi: 10.1038/nrd.2017.65. 
6 Dilts, D., Sandler, A.B. (2006). Invisible Barriers to Clinical Trials. doi: 10.1200/JCO.2005.05.0104 
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Specifically, he points to automation as a means to mitigate risk inherent in manually 
completing clinical research administration tasks while improving task execution efficiency7. 
Study status reports are an example of a regularly required task that could be automated to 
avoid reporting errors and to save report preparation time. Furthermore, automated study 
status reports based on high quality data can enable sponsors to act on new information 
quickly and with confidence while allowing clinical research administrators time to handle 
other vital tasks. 
Malikova discussed the problems faced in clinical trial execution due to increasing 
protocol complexity and how the industry is adapting by creating innovative methods of 
optimization both in study design and execution8. She noted the importance of data from 
previous studies in enabling optimization throughout a study’s life, especially during the early 
development phase. Clinical research administration professionals are uniquely positioned to 
enable this time saving early development phase technique by acting as stewards of high 
quality administrative data. Such information can be effectively used to categorize studies 
into specific clusters for further analysis that can help researchers and administrators alike 
determine the best course of action to take that will lead to an accepted and efficient study. 
Smuck et al. developed a thorough protocol complexity scoring system which has been 
adopted by numerous institutions as an effective tool to gauge study complexity and work 
burden. The tool, presented in the Ontario Protocol Assessment Level: Clinical Trial 
Complexity, considers common clinical research-related tasks under categorized groups, a 
                                                 
7 Regan,B., (2017). Can Technology Foster Better Collaboration? Applied Clinical Trials. from: 
http://www.appliedclinicaltrialsonline.com/can-technology-foster-better-collaboration 
8 Malikova, M.A. (2016). Optimization of Protocol Design: A Path to Efficient, Lower Cost Clinical Trial 
Execution. doi: 10.4155/fso.15.89 
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significant number of which are clinical research administration tasks9. The fact that 
administrative tasks were considered enough of a complicating factor to be included in the 
OPAL complexity scoring system speaks to the importance of enabling clinical research 
administrators to utilize tools that improve their efficiency without sacrificing quality. 
Data Monitoring Committees (DMCs) or Data Safety Monitoring Boards (DSMBs) are 
independent safety oversight bodies required for large, randomized, multisite clinical trials10. 
Organizing these committees requires a significant amount of time and coordination. 
Furthermore, studies may not begin until the first meeting of the committee, which in addition 
to the committee typically involves the principal investigator, sponsor, regulatory affairs 
personnel, data collection entity, and independent safety monitors.   
Clinical research administration professionals may find themselves tasked with 
coordinating committee organization. Coordination activities can involve  identifying 
committee member candidates with specific expertise, organize their conflict of interest 
(COI) analysis, and coordinating data reviews with them11. This process was previously time 
consuming and cumbersome, as work was exclusively conducted manually. To enable more 
efficient committee organization while managing an ever-increasing number of studies, some 
NIH divisions have organized the creation new systems dedicated to committee and safety 
data management that mitigate human error and save time. 
In summary, the number of clinical trials entering the the clinical trial pipeline is 
increasing every year. Additionally, the overall process for designing, obtaining approval, and 
                                                 
9 Smuck, B. et al. (2010). Ontario Protocol Assessment Level, Clinical Trial Complexity Rating Tool. doi: 
10.1200/JOP.2010.000051. 
10 Food & Drug Administration. (2006). Guidance for Clinical Trial Sponsors. From: 
https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm127073.pdf 




completing a clinical trial are also increasing. As additional steps are added to the process, 
everyone involved in facilitating the clinical trial lifecycle will experience increasing burden 
in workload. Concerns over trial design complexity and amount are significant enough that 
institutions have developed ways to assess workload burden based on a trial’s design. 
Chapter 3. Need(s) Assessment 
 
As demonstrated in the literature, the amount of clinical trials being submitted and 
initiated is trending upwards. Simultaneously, the means by which these trials are assessed 
and conducted are becoming increasingly complex with each year. Numerous research 
projects have elucidated the nature of trial complexity and the means by which that 
complexity may be alleviated. However, none of these research projects have provided 
methods specifically for clinical research administration related tasks to be completed more 
efficiently, despite many articles pointing towards clinical research administration as a source 
of study complexity and long development times. Furthermore, should the amount of clinical 
trials and their complexity continue at increase at the current rate, existing processes and 
procedures utilized by clinical research administration professionals may be insufficient to 
maintain current task completion rates and may in fact become slower. While needed, 
proposing a mass implementation of broad and sweeping changes across the clinical research 
administration field is neither practical nor reasonable. Instead, clinical research 
administration professionals must be equipped with tools that enable them to drive 
transformation in clinical research operational and administrative conduct. Using this grass-
roots approach, the pipeline through which protocols start at concept and end in study close-
out and final clinical study report will be able to handle the increasing flow of ever more 
complicated studies without slowing down.  
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Chapter 4: Project Description 
4.1 Description 
As evidenced in the literature, the burden of clinical research administration workload 
remains a concern among policy makers and leaders in the United States health research 
enterprise, as there is a continued trend towards higher workloads that may be difficult to 
handle utilizing standard approaches. This project seeks to provide practical knowledge and 
practical solutions from the fields of data management and data science that clinical research 
administrators can utilize in their day-to-day work activities. This goal would be achieved by 
introducing clinical research administrators to core concepts from data-centric professional 
fields and providing clinical research administration focused tools to assess administrative 
tasks for opportunities to utilize data-centric approaches. Engaging in this approach can 
benefit clinical research administration professionals now by expanding their skill sets and 
knowledge to augment their institutions administrative efficiency, and in the future by 
helping clinical research administrators prepare for the above-mentioned trends of increasing 
workload.  
Chapter 5. Methodology 
5.1.1 Project Methodology Overview 
This project will utilize a practical approach for educating clinical research 
administrators by identifying relatable tasks within the clinical research lifecycle. These tasks 
will then be framed in a way that best practices and principles for data management can be 
applied. Best practices will be taken from the Good Clinical Data Management (GCDMP) 
guidelines. This approach will also allow for tools to be introduced to readers in a logical and 
natural manner, where each step in the education process leads to the creation of a unique tool 
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which can be adjusted by the reader to suit their specific needs in day-to-day clinical research 
administration activities.  
It is important to note that this project is not intended to encompass all possible 
clinical research administration scenarios. Instead, this project is meant to provide clinical 
research administration professionals with a general overview of how best practices and 
trends from data-centric professional fields, such as data management practices and 
automation implementation, might be applied in the course of their normal work-related 
tasks. This project may be expanded upon by future researchers to cover more specific topics 
and further provide tools and educational materials that prepare clinical research 
administrators for the future, both in terms of managing increasing workloads and acting as a 
grass-roots force for transformation in the clinical research process.  
The project will culminate in a set of tools and resources which clinical research 
administration professionals can refer to as examples and adjust as needed to suit the tasks 
they must complete in their work. Example tools that will be provided include a checklist of 
questions to determine if a task is conducive to data management principle application, a 
summary of clinical data management practices and principles in the context of clinical 
research administration, and basic and advanced example scenarios where data-centric 
approaches to clinical research administration tasks enable improved work efficiency through 
automation using standard office programs and scripts developed for this project using the 
Python programming language. To that end, it is necessary for this project to narrow its scope 
of work in two steps.  
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5.1.2 Establishing Project Scope 
First, this project will define what a clinical research administrator is and the type of 
work they are engaged in. This definition will be backed by documentation from academic 
literature and professional organizations. Second, this project will limit common tasks in the 
clinical trial process to two task types contributing to study initiation (e.g. protocol 
development stages) and two task types executed during the course of the study (e.g. study 
recruitment monitoring). The project will proceed to identify the types of tasks in the clinical 
research lifecycle where clinical research administrators are likely to be involved.  
5.1.3 Clinical Component- Methodology and Rationale 
To identify common clinical research administration tasks, this project will analyze 
the Good Clinical Practice (GCP) guidelines created by the International Conference on 
Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human 
Use (ICH). This document provides standards for the “design, conduct, performance, 
monitoring, auditing, recording, analyses, and reporting of clinical trials” designed to protect 
a study’s credibility and the rights of recruited study subjects12. Specifically, an overview of 
ICH GCP E6 (R2) will be used, as this addendum to the original GCP guidelines provides 
additional guidance and best practices that account for the increased use of electronic health 
care records and IT technologies that improve the efficiency and credibility of clinical trials. 
This document will also be used later as an additional source of examples of where data-
centric approaches to clinical research administration tasks.  
Initially, this project considered utilizing Dilts’ extensive mapping of the clinical trial 
process because the literature review identified him as the foremost researcher of the clinical 
                                                 
12 https://ichgcp.net/ 
18 
trial life cycle and its increasing complexity. A significant amount of the literature related to 
this topic came from Dilts. However, mapping created from Dilts’ research was extremely 
narrow in terms of study Phase and therapeutic area. This project seeks to provide an 
overview of generalized clinical research lifecycle steps and data-centric approaches to these 
steps. Therefore, the ICH GCP guidelines were chosen over Dilts’ research.  
The number of steps and location of these steps within the clinical trial lifecycle will 
be limited as explained above. These steps will be identified by (1) their presence in ICH 
GCP documentation in the context of tasks within the purview of the clinical research 
administrator definition as established earlier in the project and (2) their relevance to the 
scope of work as per this paper’s definition of a clinical research administrator.  
For example, ICH GCP guidelines discuss establishing an Independent Data 
Monitoring Committee (IDMC). These Committees can be known by multiple names, such as 
Data and Safety Monitoring Board or Safety Monitoring Committee. Clinical research 
administrators may be required to coordinate or organize the creation of such Committees, 
which involves a significant number of steps. Such a task would be a suitable candidate for 
use in this project as an educational example.  
Once four tasks are identified (that is two tasks contributing to study initiation and 
two tasks during the study), a general overview of the necessary work to complete these steps 
will be provided. With the clinical scope established, the project will proceed to the data-
focused component. 
5.1.4 Data Management Component- Methodology and Rationale 
An overview of Good Clinical Data Management Practices (also known as GCDMP) 
will be introduced to the reader. GCDMP are a set of guidelines and methods of best practices 
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for clinical data and electronic records management set forth by the Society for Clinical Data 
Management (SCDM)13. While a general overview of the document will be established, 
concepts and practices relevant to the tasks selected in the narrowed clinical research 
administration component will be reviewed in detail. Specifically, guidelines will be 
compared to the steps needed to complete the tasks identified using through the method 
described above in the clinical component section. The objective is to guide readers into 
thinking about their tasks from a data-centric perspective and to consider GCDMP in the 
context of their work.  
5.1.4 Planned Output – Practical Application of Practical Knowledge 
The above approach will lead to the introduction of a checklist readers can use as a 
starting point to assess GCDMP applications for their professional tasks, adjusting as required 
for their unique situation. Additionally, the utilized guidance from GCDMP will be presented 
in a way that fits the context of clinical research administrator activities. This approach is 
used to further encourage clinical research administration professionals to think about 
GCDMP and their day-to-day tasks and to demonstrate how guidelines can be modified to 
suit unique needs. By seeing how GCDMP can be adapted to suit administrative work, other 
clinical research administration professionals may continue to “translate” other best practices 
found in GCDMP.  
With GCDMP and its application to clinical research administration introduced, the 
project will guide readers from practical education to practical execution of what has been 
presented thus far. Using the four previously identified tasks in the clinical research lifecycle 
and the steps required to complete them, scenarios which demonstrate how these tasks can be 
                                                 
13 https://www.scdm.org/publications/gcdmp/ 
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completed using a data-centric approach. Emphasis will be placed on demonstrating how 
utilizing GCDMP can enable automation in clinical research administration tasks with 
common office programs. These scenarios will culminate in a step-by-step instructional guide 
to complete the scenario task. The guide will be created in a modular way, allowing readers to 
adjust the tool for their unique needs.  
In addition to simple automation methods using office programs, advanced 
automation methods will be presented. These advanced methods will further encourage 
clinical research administration professionals to visualize their work flow and how data 
structures within it can move and be adjusted to create their final product. Because the 
advanced automation methods utilize a programmatic approach, step-by-step instructions will 
not be practical. Instead, a walkthrough of the program’s concept will be provided to assist 
readers in understanding the approach and utilizing it in their professional tasks. The final 
code for each program will be included in the Appendix of this project. Advanced methods 
will be presented to show readers how programmatic approaches to clinical research 
administration are feasible and executable by anyone. The advanced methods are also 
included to demonstrate the practicality, readability, and easily grasped syntax of the Python 
programming language when used for clinical research administration. 
Chapter 6. Project Results and Discussion 
6.1. A Definition of Clinical Research Administration 
There is no single definition limiting what clinical research administration is. 
Numerous educational programs and offices focused on clinical research administration exist 
in various institutions. While no single definition exists, overlap in many clinical research 
administration duties is found when reviewing mission statements and offered services from 
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the aforementioned offices and other sources, such as professional organizations and 
academic publications.   
Rush University’s Office of Clinical Research Affairs (RU OCRA) defines their scope 
of work by providing a definition of clinical research administration. The office defines 
clinical research administration as the facilitation of administrative and financial aspects of 
clinical research14. Among their goals, the office seeks to ensure that PIs and research teams 
are audit ready, studies start in an efficient manner, and clinical research related activities are 
effectively executed. RU OCRA further expands upon the ways that they support their 
investigators in clinical trials, listing activities such as clinicaltrials.gov application support, 
synchronization of protocol related documents prior to contract execution, and research 
coordinator support.  
The Society of Research Administrators International (SRAI) offers training sessions 
for a variety of research administration related areas, including clinical trials research 
administration15. The training session covers elements crucial to clinical research 
administration, including protocol review, recruitment, compliance, and risk management and 
analysis.  
The Association of Academic Health Centers (AAHC) released a report in 2009 
discussing the increasing importance of clinical research administrator activities before, 
during, and after a clinical trial16. In an attempt to quantify the extent of clinical research 
administration’s importance in clinical research execution, the report sent a survey to eight 
institutions asking them to identify clinical research administration tasks common to all 





entities. The survey’s results identified fourteen tasks that all surveyed institutions shared in 
common. These tasks were broad in their subject matter. Among the fourteen tasks identified 
in the report are protocol development, defining standard of care, patient recruitment and 
scheduling, and compliance. 
Moffitt Cancer Center’s Clinical Trial Office (MCC CTO) provides a list of clinical 
trial administration tasks which the office executes on behalf of investigators17. These tasks 
include providing information management support for clinical trials, ensuring study 
compliance, submitting regulatory documents, adverse event reporting, and data collection. 
The University of Arkansas for Medical Science Translational Research Institute 
(TRI) developed a system dedicated to facilitating fundamental clinical research 
administration related tasks18. The system, named CLARA (CLinicAl Research 
Administrator), has specialized modules for interfacing with various oversight committees, 
mapping adverse event reporting workflows, and facilitating general clinical trials 
management. 
The Society of Clinical Research Associates (SOCRA) provides what may be the 
most comprehensive explanation of what clinical research administration entails19. As 
demonstrated thus far, clinical research administration encompases a broad range of tasks. 
SOCRA recognizes and takes into consideration the diversity of work a clinical research 
administrator may be required to complete. First, SOCRA states that clinical research 
administration professionals may fall under different work titles, including coordinator, data 
manager, and regulatory affairs manager. Second, the duties listed are as varied as the titles a 





clinical research administrator may work under. These duties include but are not limited to 
data collection, data monitoring, committee coordination, participant recruitment, preparation 
of various study progress reports, and preparation of adverse event reports. 
Another duty clinical research administrators may handle relates to independent data 
monitoring committees (IDMC). While 21 CFR does not explicitly require the use of IDMCs 
or data and safety monitoring boards (DSMB) outside of emergency settings (21 CFR 
50.24(a)(7)(iv)), the NIH requires that each institute and center under its purview maintain a 
system to manage and implement safety oversight for patients in clinical trials. Some federal 
offices still require IDMCs for some or all studies regardless of 21 CFR. For example, the 
National Institute of Allergy and Infectious Diseases (NIAID), an institute under the NIH, 
requires IDMCs for “all randomized clinical trials of any phase that involve both investigator-
masked interventions and enrollment of greater than 100 subjects”20. NIAID’s Division of 
Microbiology and Infectious Diseases (DMID) utilizes a support contractor called the Safety 
Oversight Committee Support (SOCS) group to facilitate the organization, coordination, and 
management of these committees. In addition to committee management, the group’s 
activities encompass a myriad of clinical research administration tasks including serious 
adverse event processing, study progress reporting, and clinical document management.  
6.2. Common Research Administration Duties 
As shown above, clinical research administration duties can greatly differ from 
professional to professional. However, there are certain duties that are continually mentioned 
across all information sources common to clinical research administration. Furthermore, these 
common duties are not relegated to one step within the clinical research lifecycle. For 
                                                 
20 https://www.niaid.nih.gov/research/safety-oversight-clinical-research 
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example, a critical duty that clinical research administrators may be tasked with mentioned in 
multiple information sources was protocol development. A Protocol is a comprehensive plan 
by which a trial is conducted, explaining how each component is carried out, elucidating 
eligibility criteria, and timelining the length of the study21. Development occurs before a 
study is approved to begin and recruit its first participant. Another critical duty a clinical 
research administrator may be tasked with, regulatory compliance, occurs throughout a 
study’s active period and beyond. All tasks are related to tasks outside the medical science of 
a clinical trial, such as the treatment of patients, execution of medical therapies, and design of 
patient care procedures. This leaves tasks related to operations, management, and 
administration not necessarily relegated to one type of duty (e.g. budgeting).  
Therefore, this paper will define clinical research administration as the management 
and execution of any and all administrative and/or operational duties related to clinical 
research development and execution. This definition can encompass all above mentioned 
duties and reflects the diverse nature of the clinical research administrator. With the breadth 
and depth of clinical research administration’s scope established, specific duties will be 
focused on for analysis and application of data management best practices and automation 
potential. These duties will be categorized into tasks before study start and after study start 
and are selected based on their subject matter focus’ presence in ICH GCP.  
It is important to note that selected duties could include various subtasks that must be 
fulfilled in order for a duty to be completely fully. This paper’s scope is establishing a 
conceptual foundation of applying data management principles and automation to clinical 
research administration and does not seek to cover each possible subtask within or 
                                                 
21 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198475/ 
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permutation of the above-mentioned duties. Therefore, to ensure that example use cases are 
comprehensive and practical, duties will be further narrowed to specific subtasks aimed at 
specific goals. The below section defines the duties to be focused on and their narrowed 
scope. 
6.2.1 Common Duties Before Study Startup 
6.2.1.1 Protocol Development 
The protocol development stage is where the processes and procedures for executing a 
clinical trial are fully fleshed out in the form of a document called a protocol. Multiple 
entities can be involved in this process, where sponsor and government personnel work 
together to create what can be seen as the “manual” for how to complete a study. Al-Jundi 
and Sakka published an article reviewing common components and benefits of a clinical 
protocol22. Of interest to this paper is the Methodology section’s data collection components. 
Al-Jundi and Sakka indicate that the Methodology section “defines the variables and 
demonstrates in detail how the variables will be measured.” As per this paper’s definition 
(and the information sources used to establish that definition), a clinical research 
administrator may be tasked with contributing to a protocol’s development by identifying 
relevant data types for capture during the study. This can involve in-depth literature reviews 
or reviewing past protocols to identify data commonly captured for study’s similar in nature. 
6.2.1.2 IDMC Organization 
IDMCs can be known by a host of other names such as Data and Safety Monitoring 
Board (DSMB) or Safety Monitoring Committee (SMC). In trials such as those under the 
purview of NIAID DMID, these committees must meet and provide their recommendations 
                                                 
22 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198475/ 
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on a study’s design from a safety perspective before they can continue. Clinical research 
administrators tasked with organizing such committees can expect to be involved in 
identifying possible members by their professional expertise, drafting invitation materials, 
organizing conflict of interest reviews, and providing administrative support to committee 
members from the first organizational meeting that allows a study to begin through to the 
study’s end. 
6.2.2 Common Duties After Study Startup 
6.2.2.1 Protocol Deviations 
The first post-study startup activity this paper will focus on relates to protocol 
deviations. Protocol deviations include any actions that occurs outside the defined parameters 
of the protocol. Deviations can occur for a number of reasons, such as study staff 
intentionally deviating from protocol-defined procedures out of concern for a participant’s 
safety. Clinical research administrators involved in monitoring or processing protocol 
deviation reports from study sites may find themselves assigned as stewards of deviation 
information, having to extract data from report forms or design deviation collection methods.  
6.2.2.2 Study Status Reporting 
Whether stakeholder or federal agency, specialized study operations and 
administrative reports may be requested as regularly submitted deliverables. The frequency 
and subject matter of these reports can greatly vary. To illustrate, consider a clinical research 
administrator assigned to safety oversight coordination and support for ten clinical trials. For 
each trial, they must provide a weekly report on meeting activity between the study sites and 
federal agencies, a monthly report on data reviews by IDMCs, a monthly report on number of 
deviation and serious adverse events that occurred per study, and a general study benchmark 
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progress report. As the trend of ever increasing clinical trials identified in the literature 
review continues, reporting duties become increasingly work heavy. 
6.3 Clinical Research Administration and Good Clinical Data Management Practice 
GCDMP are a set of guidelines and methods of best practices for clinical data and 
electronic records management set forth by the Society for Clinical Data Management 
(SCDM). The primary focus of the document is providing recommendations related to 
ensuring regulatory compliance in the realm of clinical data management. However, the 
document also contains practical suggestions and methods by which readers can meet said 
recommendations. Covering a total of 20 sections, GCDMP encompasses best practices for 
all clinical data-related components of a clinical trial in technical depth. This paper will focus 
on three specific sections containing recommendations and best practices relevant to clinical 
research administration; Data Entry and Processing, Dictionary Management, and Assuring 
Data Quality. 
6.3.1 Data Entry and Processing 
GCDMP states that the objective of data processing is to “efficiently produce quality 
data for analysis.” Typical clinical data analysis involves processing data through statistical 
models and programs (e.g. SAS). Data quality directly impacts the reliability of clinical data 
analysis. Clinical research administrators should pay particularly close attention to the 
concept of data entering a model and exiting the model as a calculated result. This concept, 
known as Input/Output (I/O), establishes the importance of good data management in clinical 
research administration. Instead of manually completing deliverables, such as IDMC 
invitations, clinical research administrators can think about their task from an I/O model 
perspective, where data can be input into a program, script, or template, with output being a 
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final product ready to deliver to needed stakeholders. Higher quality data results enable high 
quality automated output with little to no need for time consuming quality checks. I/O is a 
vital conceptual foundation for clinical research administrators seeking to apply data 
management and automation to their work. 
Whatever clinical research administration data one may utilize, GCDMP provides 
relevant best practices to ensure the data’s integrity in the course of its use. Most relevant is 
the best practice of ensuring quality control in one’s data. The GCDMP provided example of 
a quality control measures is to periodically inspect samples of data then take corrective 
action if errors are found. Note that a data source does not need to be a large web-based 
database. A data source is simply where data is located, such as a spreadsheet. Whether a data 
source is handled by one or more clinical research administration professionals in a working 
environment, such a measure helps ensure data quality. There are two best practices for data 
entry and processing that, when adjusted to fit the correct context, are relevant to clinical 
research administration: 
● Use written procedures that describe data processing steps and required quality level.  
● Address the purpose, characteristics, and complexity of each data source.  
6.3.2 Data Dictionaries 
Data dictionaries define specialized coding criteria typically used for clinical events, 
medical history, and diagnosis data types. While clinical research administrators are unlikely 
to be involved in this technical component of clinical research, the concept of defining data 
types is useful for clinical research administrators. To ensure high quality data is maintained, 
it is important to define what data is being collected, why that data is collected, where is the 
data coming from, and what the data will be used for. Establishing these definitions helps 
29 
maintain data integrity and ensures the right data is reliably present and usable. There are two 
best practices for data dictionaries that when adjusted to fit the correct context are relevant to 
clinical research administration: 
● Establish a process for evaluating a change in a dictionary.  
● Store all versions of dictionaries for future reference. 
6.3.3 Maintaining Data Quality 
As previously stated, high quality input (data) ensures high quality output (results). If data 
is managed poorly, the benefits of its use in clinical research administration will not be 
realized and can negatively impact quality. Specific processes are needed to ensure data 
quality is maintained from the moment it is collected. This concept again relates to the 
concept of I/O. There are two best practices for data quality during collection that when 
adjusted to fit the correct context are relevant to clinical research administration. 
● Include as few steps as possible in the data collection and data handling processes to 
eliminate the chances for error.  
● Collect only data essential for intended use.  
6.4 Assessing GCDMP Suitability in Clinical Research Administration Duties 
Consistency and dependability are continually present themes throughout GCDMP. 
These concepts are applicable to clinical research administration, as categorizable data flows 
through clinical research administration work processes. Furthermore, this categorizable dtaa 
can have a dependable source related to it. Patterns and themes emerge when stepping back to 
assess clinical research administration work, how it is achieved, and what is required to 
achieve it. Doing so allows one to exploit the patterns in a systematic way, enabling the 
confident use of automated processes to handle certain tasks, thus easing workload burden. 
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To identify these patterns and categories, tasks should be considered with the data 
management concept of I/O in mind. Answering the questions in the below tool can help one 
identify whether a task could easily utilize GCDMP principles and thus immediately (or near 
immediately) be automated: 
Question If Yes If No 
Is the input required for the task in a structured (e.g. tabular 
protocol deviation data) format? 
Continue Continue 
If not structured (e.g. a narrative protocol amendment), could 
the input be easily reformatted to be structured? 
Continue Stop 
Is the output’s structure consistently the same (e.g. a report 
with a significant amount of boilerplate language)? 
Continue Stop 
Are the output’s constants (e.g. boilerplate language) and 
variables (e.g. form field data) consistently located in the 
same place in the final product? 
Continue Stop 
Are the steps in the task needed to get from input to output 
product always the same? 
Continue Stop 
 
It should be noted that many of the “stop” points above are not an impassable barrier 
to automation given enough experience. For example, even if a task’s input contains 
unstructured data, the data can be reshaped into a structured format programmatically. 
However, doing so would require knowledge and experience most clinical research 
administrators will not have or will need time to develop. For immediately implementable 
and effective data management and automation in clinical research administration, data 
should be structured until such time that a clinical research administrator expands their skill 
set to include scripting languages such as Python, R, JavaScript, or Julia. 
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6.5 Examples of Applying GCDMP  
To present how GCDMP can be utilized for clinical research administration tasks, 
consider the following use cases in common clinical research administration tasks established 
earlier. These examples are presented both to illustrate how GCDMP best practices can be 
applied and the benefits of applying them. The benefits focused on are expedient informed 
analysis and task automation. Informed analysis using previously completed studies can 
benefit clinical research administrators working within the steps before a clinical trial begins 
by providing insight from structured and easily parsed data sources. Process automation can 
ensure that studies and clinical research administrators are not hindered by the increased 
workflow accompanying the increasing number of clinical trials entering the lifecycle 
pipeline. 
6.5.1 Identifying Necessary Data Points During Protocol Development  
Clinical trials have a variety of characteristics that differentiate how they operate and 
what their expected outcomes are. These characteristics include study phase, target 
population, target disease, and study endpoints. While this data is not necessarily tabular in 
format, it can be captured on an ongoing basis in a table. Alternatively, if data is (a) located 
together on one page and (b) all contain a delimiter (e.g. “:” in Disease: Influenza), one could 
easily paste this text into a spreadsheet and use the “Text to Column” function to split text by 
a shared delimiter into multiple columns. Once done, the data can be transposed with an 
additional copy and paste to fit a table format. This in turn creates a “protocol profile,” 
painting a picture of a specific protocol by key characteristics (see below example).  
Protocol 
Number 




The more characteristics utilized, the more specific one can make their comparative 
analysis of the protocol in development and similar previously approved protocols. Protocol 
specific data points and types could then be directly matched with their study.  
The most important point to bare in mind when executing this approach is that all 
characteristics must be linked to a single unique identifying data type (or column). In 
database development, this data type is referred to as the primary key. The key uniquely 
identifies an individual record or row in a table, allowing the row to be referenced 
programmatically to  other tables quickly and reliably. For this example, the key would be a 
clinical trial’s identifying ID, such as a protocol number. If an institution uses a study ID 
scheme that differs from other involved entities, then it is important to include all other IDs in 
a table matched to the institution’s ID for a study. This will allow collected data to be easily 
referenced regardless of entity source. This approach ensures that protocol specific 
characteristics are kept to their protocols and enables reliable assignment of additional types 
of data, such as data capture points, for future comparative analysis. This approach can 
provide a foundation which clinical research administrators can use in identifying needed data 
types to capture in the study without having to start from scratch with a literature review. 
6.5.2 IDMC Formation Organization  
Organizing an IDMC requires inviting medical professionals with expertise in the 
medical field of the study that the IDMC is intended to oversee. For example, DMID requires 
a welcome letter, contact information sheet, conflict of interest form, and cover email for 
IDMC candidates. While these output items may seem extremely varied, they are not beyond 
application of the GCDMP best practices mentioned above. Specifically, when considering 
what data is essential for each output in this task and the processing steps required to go from 
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data to formatted output, modeling an automated solution is relatively easy. The input for this 
task consists of variables (e.g. names, addresses, protocol numbers, etc) placed within large 
chunks of constants (templated language). The language, structure, and general makeup of the 
output without the variables included can be templatized, leaving placeholders for needed 
variables. Functions found in spreadsheet and word processing programs can enable the 
automatic generation of all needed email language and documents customized for their 
intended recipients in mere seconds. This function, more colloquially known as mail merge, 
utilizes word processor templates and spreadsheet columns to quickly generate documents.  
Columns are named within a word processing program’s mail merge function that 
match columns in a data source containing necessary information (e.g. contact’s email 
address, phone number, full study title). Once the tags are placed in the template, it can be 
linked to the spreadsheet data source. Each row in the source acts as a unique instance of the 
document to be generated from the template, allowing users to generate as many documents 
as necessary. This approach can be executed without any programming. 
This form of automation can be taken one step further using a scripting language. An 
example of a Python-based implementation of automatic generation of IDMC candidate 
invitations can be found in Appendix A. Using data contained in a spreadsheet, the script 
takes contact information and trial information and places them into templated documents and 
emails for as many recipients as needed. When run from a command prompt in the folder 
containing the main script, the following process occurs: 
1. User is prompted to enter "clinical trial number, first name, last name, role, 
noprior/prior-start/mid." 
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a. Subject matter experts can be invited under a number of different scenarios 
requiring unique language. To account for this, the "noprior/prior-start/mid" 
identifies which type of templated communication the script will populate. 
b. “noprior”=intended recipient has not yet been contacted by someone (e.g. a 
federal employee) about this invite ahead of it being sent. 
c. “prior”=intended recipient has been contacted by someone (e.g. a federal 
employee) about this invite ahead of it being sent. 
d. “start”=intended recipient is being invited at the beginning of the clinical trial. 
e. “mid”=intended recipient is being invited after the clinical trial has started. 
2. User can enter as many contacts as they desire. When finished, they may press "Enter" 
on an empty prompt. 
3. Data source sheets are parsed for the appropriate information. The final product is 
placed into a dictionary to allow for the fastest package generation possible. 
4. Script will select and populate Word and email templates based on their file name. 
a. Word templates are populated by pre-placed mail merge tags and dictionary 
data. 
b. Email templates are populated by string format tags and dictionary data. 
5. Outlook email is generated and fully populated with email address, attachments, and 
email body fully formatted and ready to send. 
 
6.5.3 Protocol Deviation Reporting and Monitoring  
Clinical research administration professionals tasked with processing and maintaining 
protocol deviation data will deal with data from multiple deviation cases simultaneously, and 
in some cases from multiple studies or study sites. The method by which deviations are 
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reported can vary. However, depending on regulatory requirements for a study, standardized 
forms are efficient ways to capture protocol deviation data. Specifically, table style forms 
allow for simplified data capture and tracking via spreadsheet. Whether or not the form is 
contained in a word processing program-related file, table formatted forms can be placed 
from any source are more readable by spreadsheet programs without formatting corruption. 
Data fields will reliably be present in the same spreadsheet cell every time the table is placed 
into a spreadsheet program, allowing the use of spreadsheet formulas to retrieve data and 
place it in the appropriate column. Much like IDMC organization, standardized tabular forms 
allow for automated data extraction and tracking through programmatic means. An example 
program implemented in Microsoft Excel using its built in the Visual Basic (VB) scripting 
language interpreter can be found in Appendix B. The program is simply pasted into a macro 
script editing window for a spreadsheet and run directly from the spreadsheet. 
6.5.4 Study Operations and Administration Reporting  
This particular duty is an excellent example of a clinical research administration duty 
where GCDMP best practices can be applied. Recall the GCDMP best practice regarding 
dictionaries that define data types, sources, and purposes of each. Identifying reports 
repeatedly requested, their content, and sources that contribute to each report, then using 
those to create a data dictionary can prove to be a boon to administrators. Doing so can 
identify common data points and sources across reports, allowing for relevant columns to be 
called from different spreadsheet sources, generating a report. With standardized report 
formats, columns, and identification of key columns that uniquely identify records within 
disparate reports, clinical research administrators can generate ad hoc reports of any kind 
when requested through features built into spreadsheet programs (e.g. VLOOKUP), so long 
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as the data the report is intended to focus on is part of a clinical research administrators 
overall data management approach. A more advanced approach to leveraging benefit from 
applying GCDMP to this task can once again by demonstrated using the Python programming 
language. In Appendix C, an example program is provided that generates a weekly report 
subset taken from a much larger reporting source that is attached to an automatically 
formatted and written email ready to send the report to relevant stakeholders. 
Chapter 7. Recommendations and Discussion 
7.1. Introduction   
The trends shaping the future clinical research environment necessitates the need for 
new approaches to be considered in executing clinical research administration duties. 
Specifically, a multidisciplinary approach embracing core principles from GCDMP and 
applied to clinical research administration can facilitate easily implemented automation of 
specific duties, thus easing workloads on administrative and operation staff and ensuring 
clinical trials are able to pass through the pipeline without administrative hindrances despite 
the increasing volume of studies within the pipeline. 
7.2. Recommendations and Discussion of Recommendations 
This paper sets forth the following recommendations for policy makers and leading 
entities within the clinical research enterprise. 
1. Consider developing an Artificial Research Administrator (ARA) A.I. to process the 
more mundane yet high volume administrative and operational tasks and slowly 
expand its capabilities the longer it remains operational. This A.I. would utilize 
natural language processing techniques to read, understand, and execute requests via 
email from entities within a clinical research environment. A prototype for such an 
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A.I. was developed for this paper in the form of a simple machine learning algorithm 
(MLA). This MLA uses term frequency-inverse document frequency (tf-idf) to stem 
terms and calculate relevance scores, which are then used in a logistic regression-
based model. As of this paper, the model can process email-based text requests and 
predict appropriate categorization and actions to take with 93% accuracy. A new 
model is currently being developed utilizing a tensorflow-based artificial neural 
network. 
2. Engage in a research study to identify all clinical research administration duties 
throughout the entire clinical research lifecycle. Duties must be common to all clinical 
trials. 
3. Collaborate with policy makers to identify each duty’s expected output format, 
anticipated input sources, and the process used today by which input would be 
transformed into acceptable output. 
4. Identify duties that prove to be the most significant administrative bottlenecks in the 
clinical trial life cycle across all clinical trial types and phases. 
5. Federal entities should collaborate with industry and academic institutions to develop 
open-source easily implementable automated solutions to provide clinical research 
entities with. 
Chapter 8: Conclusion 
The clinical research process is seen by both industry and government as outdated and 
in dire need of modernization. Failing to do so will delay the release of medical products that 
could significantly improve quality of life for patients, and in some cases save a patient’s life. 
The regulatory and legal complexity of overhauling the clinical research pipeline translates to 
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a significant amount of time passing before the process can be modernized to account for the 
increasing number of clinical trials entering the pipeline.  
Clinical research administrators throughout the clinical research lifecycle are familiar 
with their unique part of the pipeline and could facilitate the modernization process at a grass-
roots level by applying principles and best practices from other professional fields to their 
work (namely, GCDMP best practices). Applying these practices will enable clinical research 
administrators to leverage the data flowing around them everyday in enabling leadership to 
make informed decisions as well as automating various processes necessary for a clinical trial 
to continue through the pipeline in its lifecycle. Should enough clinical research 
administrators apply the best practices and methods for leveraging clinical research 
administration data set forth in this paper, the modernization of the clinical trials process may 
be completed faster than thought possible. 
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Appendix A. – IDMC Candidate Invitation Generator 
An example program utilizing word processor templates and spreadsheet data sources to 
generate IDMC invitations and associated documents automatically. 
1. import pandas as pd   
2. from mailmerge import MailMerge   
3. from datetime import date   
4. import win32com.client as win32   
5. from datetime import datetime, timedelta   
6. import email_templates   
7. path1 = 'C:/path/to/data/input/'   
8. path2 = 'C:/path/to/template/input/'   
9. outpath = 'C:/path/to/attachment/output/folder/'   
10.    
11. protocol = []   
12. frst_names = []   
13. lst_names = []   
14. temp_type = []   
15. name_role = []   
16. i=0   
17. while 1:   
18.     i+=1   
19.     name=input("Enter candidate %d's protocol#, first name, last name, role, and pri
or/noprior-mid/start : " %i)   
20.     if name=='':   
21.         break   
22.     info = name.split(',')   
23.     frst_names.append(info[1].lower())   
24.     lst_names.append(info[2].lower())   
25.     name_role.append(info[1:])   
26.     protocol.append(info[0])   
27.     protocol = list(set(protocol))   
28.    
29. d0 = {'Committee_Type': ['SMC', 'DSMB'],   
30.       'Committee': ['Safety Monitoring Committee (SMC)', 'Data and Safety Monitoring
 Board (DSMB)'],   
31.       'Sentence': ['an SMC','a DSMB']}   
32. df0 = pd.DataFrame(data=d0)   
33. df01 = pd.DataFrame(name_role, columns=['First_Name','Last_Name','Role','doc_temp'])
   
34. df01 = df01.replace({'Role': {'Chair': 'the Chair', 'Member':'a Member', 'Biostatist
ician':'the Biostatistician'}})   
35. df01['etype'] = df01['doc_temp'].str.split('-',expand=True)[0]   
36. df01['name_key'] = df01['First_Name'] + ' ' + df01['Last_Name']   
37. df01['name_key'] = df01['name_key'].str.lower().apply(lambda n: n[:3] + '.' + n[n.fi
nd(' '):])   
38. df01 = df01[['name_key','Role','doc_temp','etype']]   
39. xls1 = pd.ExcelFile(path1+'CMSReport-welcomepackage-14-09-18 13-36.xlsx')   
40. df1 = xls1.parse(xls1.sheet_names[0])   
41. df1.fillna('',inplace=True)   
42. df1['first_key'] = df1['First_Name'].str.lower().apply(lambda n: n[:3] + '.')  
43. df1['name_key'] = df1['first_key'] + ' ' + df1['Last_Name'].str.lower()  
44. df02 = df01.merge(df1, on='name_key', how='left')  
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45. df02['combined'] = df02.astype(str).add('_').sum(axis=1).str[:-1]  
46. df02['count'] = df02['combined'].str.len()  
47. df02 = df02.sort_values('count', ascending=False).drop_duplicates('name_key').sort_i
ndex() 
48. df02 = df02[['First_Name', 'Last_Name','Contact_Credentials', 'Title', 'Organization
', 'First_Address_Line',   
49.              'Second_Address_Line', 'City', 'Contact_State', 'Postal_Code','Email_Ad
dress1', 'Email_Address2',   
50.              'Work_Telephone', 'Phone','Fax_Number1', 'Fax_Number2', 'Assistant_Firs
t_Name','Assistant_Last_Name',   
51.              'Alernate_Phone', 'Assistant_Fax','Assistant_Email','Role', 'doc_temp',
 'etype']]   
52. df02.reset_index(inplace=True)   
53. df02.drop(['index'],axis=1,inplace=True)       
54. xls2 = pd.ExcelFile(path1+'CMSReport-prots-20-09-18 10-08.xlsx')   
55. df2 = xls2.parse(xls2.sheet_names[0])   
56. df2 = df2[df2['Protocol_Number'].str.lower().isin(protocol)]   
57. df2.fillna('',inplace=True)   
58. df2.reset_index(inplace=True)   
59. df2.drop(['index'],axis=1,inplace=True)   
60. df02['joincol'] = 1   
61. df2['joincol'] = 1   
62. df3 = pd.merge(left=df02,right=df2, on='joincol', how='outer')   
63. df3.drop(['joincol'],axis=1,inplace=True)   
64. df4 = df3.merge(df0,on='Committee_Type',how='left')   
65. df4['letter'] = df4['Protocol_Number']+' '+df4['Committee_Type']+' Welcome Letter -
 '+df4['Last_Name']+'.docx'   
66. df4['cif'] = df4['Protocol_Number']+' Contact Information Form -
 '+df4['Last_Name']+'.docx'   
67. df4['subj'] = 'Safety Oversight, Protocol '+df4['Protocol_Number']+', '+df4['Committ
ee_Type']+' Membership Invitation - '+df4['Last_Name']   
68. contacts = df4.to_dict('records')   
69.    
70. email_types = {'prior': email_templates.prior, 'noprior': email_templates.noprior}   
71. outpath = 'C:/path/to/attachment/output/folder/'   
72. cif = path2+'Template Contact Information Form.docx'   
73. for d in contacts:   
74.     welcome_letter = path2+'Template Welcome Letter -
 {}.docx'.format(d['doc_temp'])   
75.     doc_letter = MailMerge(welcome_letter)   
76.     welcome_email = email_types[d['etype']]   
77.     doc_cif = MailMerge(cif)   
78.     name1 = outpath+d['letter']   
79.     name2 = outpath+d['cif']   
80.     print('Package complete for',d['Last_Name'])   
81.     doc_letter.merge_pages([d])   
82.     doc_cif.merge_pages([d])   
83.     doc_letter.write(name1)   
84.     doc_cif.write(name2)   
85.     doc_letter.close()   
86.     doc_cif.close()   
87.     outlook = win32.Dispatch('outlook.application')   
88.     recipient = d['Last_Name']   
89.     prot = d['Protocol_Number']   
90.     titl = d['Protocol_Full_Title']   
91.     cmt = d['Committee']   
92.     cmt_abrv  = d['Committee_Type']   
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93.     due_date = datetime.now() + timedelta(days=7)   
94.     due_date_formatted = due_date.strftime('%d-%b-%y')   
95.     mail = outlook.CreateItem(0)   
96.     mail.To = d['Email_Address1']   
97.     mail.cc = 'SOCS@dmidcroms.com; '+d['Assistant_Email']   
98.     mail.Subject = d['subj']   
99.     mail.Attachments.Add(outpath+d['letter'])   
100.     mail.Attachments.Add(outpath+d['cif'])   
101.     mail.HtmlBody = welcome_email.format(prot=prot,titl=titl,recipient=recip
ient,cmt=cmt,due_date_formatted=due_date_formatted,cmt_abrv=cmt_abrv)   
102.     mail.Display(False)   
Appendix B. – Automatic Protocol Deviation Form Extraction Program 
Example implementation of data extraction from table style forms using Microsoft Excel 
Visual Basic scripting. 
1. Sub NewPDNFExtractCells()   
2.    
3.     Dim wb As Workbook   
4.     Dim ws As Worksheet   
5.     Dim MySheet As String   
6.     Dim r1 As Range   
7.     Dim r2 As Range   
8.     Dim r3 As Range   
9.     Dim r4 As Range   
10.     Dim r5 As Range   
11.     Dim r6 As Range   
12.     Dim r7 As Range   
13.     Dim r8 As Range   
14.     Dim r9 As Range   
15.     Dim r10 As Range   
16.     Dim r11 As Range   
17.     Dim r12 As Range   
18.     Dim r13 As Range   
19.     Dim r14 As Range   
20.     Dim r15 As Range  
21.     Dim i As Integer   
22.    
23.     Dim OpenWorkbook As Workbook   
24.     Dim OpenWorksheet As Worksheet   
25.     Dim SheetName As String   
26.    
27.     Dim Directory As String   
28.     Dim FileSpec As String   
29.     Dim MyFile As String   
30.    
31.     Directory = "C:\example\path\to\table\formated\forms\"  
32.     FileSpec = ".xlsx"  
33.     MyFile = Dir(Directory & "*" & FileSpec)   
34.     SheetName = "Table 1"  
35.    
36.     ' set local vars   
37.     Set wb = ThisWorkbook   
38.     MySheet = "Sheet1"  
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39.     Set ws = wb.Worksheets(MySheet)   
40.    
41.    
42.     Set r1 = ws.Range("A2")  
43.     Set r2 = ws.Range("B2")    
44.     Set r3 = ws.Range("D2")    
45.     Set r4 = ws.Range("E2")    
46.     Set r5 = ws.Range("F2")    
47.     Set r6 = ws.Range("I2")    
48.     Set r7 = ws.Range("K2")    
49.     Set r8 = ws.Range("L2")    
50.     Set r9 = ws.Range("M2")    
51.     Set r10 = ws.Range("N2")    
52.     Set r11 = ws.Range("O2")    
53.     Set r12 = ws.Range("P2")   
54.     Set r13 = ws.Range("Q2")   
55.     Set r14 = ws.Range("R2")    
56.     Set r15 = ws.Range("S2")  
57.     i = 0  
58.     Do While MyFile <> ""   
59.         Set OpenWorkbook = Application.Workbooks.Open(Filename:="C:\example\path\to 
table\formatted\Forms\" & MyFile, ReadOnly:=True)  
60.         Set OpenWorksheet = OpenWorkbook.Worksheets(SheetName)   
61.         With OpenWorksheet  
62.             r1.Offset(i, 0).Value = .Range("C6").Value    
63.             r2.Offset(i, 0).Value = .Range("C8").Value    
64.             r3.Offset(i, 0).Value = .Range("C4").Value    
65.             r4.Offset(i, 0).Value = .Range("C10").Value    
66.             r5.Offset(i, 0).Value = .Range("C22").Value    
67.             r6.Offset(i, 0).Value = .Range("C12").Value    
68.             r7.Offset(i, 0).Value = .Range("C15").Value    
69.             r8.Offset(i, 0).Value = .Range("C16").Value    
70.             r9.Offset(i, 0).Value = .Range("C35").Value    
71.             r10.Offset(i, 0).Value = .Range("C37").Value    
72.             r11.Offset(i, 0).Value = .Range("C38").Value    
73.             r12.Offset(i, 0).Value = .Range("C36").Value    
74.             r13.Offset(i, 0).Value = .Range("C17").Value    
75.             r14.Offset(i, 0).Value = .Range("C18").Value    
76.         End With   
77.         i = i + 1  
78.         OpenWorkbook.Close SaveChanges:=False            
79.         MyFile = Dir()   
80.     Loop    
81. End Sub   
Appendix C. – Automated Report Subset and Email Generator 
Generates a subset report from a larger report source based on date ranges. Generates a 
formatted email with the subset report attached, ready to send to relevant stakeholders. 
1. import pandas as pd   
2. import numpy as np   
3. import glob   
4. import datetime as dt   
5. import win32com.client as win32   
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6. pd.options.mode.chained_assignment = None   
7. pd.set_option('display.max_colwidth', -1)   
8. pd.set_option('display.max_columns', None)   
9. pd.set_option('display.max_rows', None)   
10.    
11. today = dt.date.today()   
12. last_week = today - dt.timedelta(days=7)   
13. tomorrow = today + dt.timedelta(days=1)   
14.    
15. path = 'C:/path/to/main/report/source'   
16.    
17. for mtracker_name in glob.glob(path+'Document Inventory Tracker*'):   
18.     mtracker_file = mtracker_name   
19. df = pd.read_excel(mtracker_file,header=None,usecols="A:O,W")    
20. df[15].replace('Other', np.nan, regex=True, inplace = True)   
21. df[15].replace('Date Updated', np.nan, regex=True, inplace = True)   
22. df[15] = pd.to_datetime(df[15])   
23. df1 = df[(df[15] >= last_week) &  (df[15] < tomorrow)]     
24. df0 = df.iloc[:2]   
25. all_dfs = [df0,df1]   
26. df2 = pd.concat(all_dfs).reset_index(drop=True)   
27. del df2[15]   
28. # df2.drop(15,axis=1,inplace=True)   
29. df2.fillna('',inplace=True)   
30. df2[3].iloc[2:] = pd.to_datetime(df2[3].iloc[2:]).dt.strftime('%m/%d/%y')   
31. df2.iloc[:,5:] = df2.iloc[:,5:].replace(1, 'Posted', regex=True)   
32. df2.rename(columns={ df.columns[4]: "type" },inplace=True)   
33. df2.rename(columns={ df.columns[6]: "m1" },inplace=True)   
34. df2.rename(columns={ df.columns[7]: "m2" },inplace=True)   
35. df2.rename(columns={ df.columns[9]: "m3" },inplace=True)   
36. df2.rename(columns={ df.columns[10]: "m4" },inplace=True)   
37. df2.rename(columns={ df.columns[12]: "m5" },inplace=True)   
38. df2.rename(columns={ df.columns[13]: "m6" },inplace=True)   
39. df2.loc[df2['type'] == 'E-REV', ['m1','m2','m3','m4','m5','m6']] = "N/A"   
40. out_path = 'C:/path/to/report/output/folder/Study Tracker Report 
Update {date:%d%b%y}.xlsx'.format(date=dt.datetime.now())   
41. writer = pd.ExcelWriter(out_path , engine='xlsxwriter')   
42. workbook = writer.book   
43. df2.to_excel(writer, sheet_name='Sheet1',header=False,index=False)   
44. worksheet = writer.sheets['Sheet1']   
45. formater = workbook.add_format({'bold':True})   
46. merge_format = workbook.add_format({   
47.     'align': 'center',   
48.     'text_wrap': True,   
49.     'border': 1,   
50.     'valign': 'vcenter'})   
51. main_format = workbook.add_format({   
52.     'align': 'left',   
53.     'text_wrap': True,   
54.     'border': 1,   
55.     'valign': 'bottom'})   
56. blank_format = workbook.add_format({   
57.     'bg_color': '#fff2cc',   
58.     'border': 1   
59. })   
60. worksheet.merge_range('A1:C1', 'Protocol Info', merge_format)   
61. worksheet.merge_range('D1:E1', 'Meeting Info', merge_format)   
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62. worksheet.merge_range('F1:H1', 'M', merge_format)   
63. worksheet.merge_range('I1:K1', 'CMS', merge_format)   
64. worksheet.merge_range('L1:N1', 'DL', merge_format)   
65. worksheet.set_column('A2:O2',28,merge_format)   
66. worksheet.set_column('A:B',10)   
67. worksheet.set_column('C:C',11)   
68. worksheet.set_column('D:P',9)   
69. worksheet.conditional_format('A1:O2',{'type':'no_blanks','format':formater})   
70. worksheet.conditional_format('A3:O'+str(df2.shape[1]+2), { 'type' : 'no_blanks' , 'f
ormat' : main_format} )   
71. worksheet.conditional_format('A3:O'+str(df2.shape[0]), { 'type' : 'blanks' , 'format
' : blank_format} )   
72. writer.save()   
73. m_email = (r"""  
74. <body>  
75. <font face = "Times New Roman" size="3">  
76. <p>Dear Mr. Smith,</p>  
77. <p>Per your request, please find attached this week’s Study 
Tracker Status Update.</p>  
78. <p>If you have any questions or concerns, please contact me directly 
at vpoonai@exampledomain.com or 301-444-5555.</p>  
79. <p>Sincerely,<br>  
80. Victor Poonai, BA<br>  
81. Safety Oversight Coordinator<br>  
82. Safety Oversight Support Team<br>  
83. </font></body>  
84. """)   
85. outlook = win32.Dispatch('outlook.application')   
86. mail = outlook.CreateItem(0)   
87. mail.To = 'johnsmith@mail.nih.gov'   
88. mail.Subject = 'Study Tracker Weekly Status Update ({date:%d%b%y})'.format(date=dt.d
atetime.now())   
89. mail.Attachments.Add(out_path)   
90. mail.HtmlBody = m_email   
91. mail  
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